A detailed history of Intech Investment Management LLC transactions in Geron Corp stock. As of the latest transaction made, Intech Investment Management LLC holds 233,992 shares of GERN stock, worth $262,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233,992
Previous 354,715 34.03%
Holding current value
$262,071
Previous $500,000 36.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$1.1 - $1.47 $132,795 - $177,462
-120,723 Reduced 34.03%
233,992 $320,000
Q2 2025

Aug 08, 2025

SELL
$1.18 - $1.62 $213,886 - $293,641
-181,260 Reduced 33.82%
354,715 $500,000
Q1 2025

May 20, 2025

BUY
$1.59 - $3.6 $292,959 - $663,303
184,251 Added 52.39%
535,975 $852,000
Q4 2024

Feb 10, 2025

BUY
$3.3 - $4.44 $359,386 - $483,538
108,905 Added 44.85%
351,724 $1.25 Million
Q3 2024

Nov 08, 2024

BUY
$4.17 - $4.99 $1.01 Million - $1.21 Million
242,819 New
242,819 $1.1 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.